Ubidecarenone

Ubidecarenone, commonly known as Coenzyme Q10 (CoQ10), is a lipid-soluble redox cofactor and endogenous antioxidant found in virtually all human cells, with the highest concentrations in metabolically active tissues such as the heart, liver, and skeletal muscle. Chemically, it belongs to the family of benzoquinone compounds and exists in two principal redox states: the oxidized ubiquinone form and the reduced ubiquinol form. Its core biological function is to serve as a mobile electron carrier within the mitochondrial inner membrane, shuttling electrons between Complexes I and II and Complex III of the electron transport chain, thereby facilitating the production of adenosine triphosphate (ATP) through oxidative phosphorylation. In its reduced state, ubiquinol acts as a potent chain-breaking antioxidant, quenching reactive oxygen species and protecting cellular membranes and lipoproteins from oxidative damage. Beyond energy metabolism, CoQ10 plays roles in membrane stabilization, modulation of mitophagy, and maintenance of mitochondrial proteostasis.

Ubidecarenone is also classified as a nutraceutical and pharmaceutical agent. It is widely used as an oral dietary supplement and has been investigated as a therapeutic candidate for conditions associated with mitochondrial dysfunction, oxidative stress, cardiovascular disease, neurodegeneration, and renal pathology. Its endogenous biosynthesis involves the mevalonate pathway, which is also targeted by statins—drugs known to deplete circulating CoQ10 levels as a side effect—making supplementation clinically relevant in statin-treated populations. Despite its established biological importance, CoQ10's extremely poor aqueous solubility and consequent low oral bioavailability have historically limited its therapeutic application, driving extensive research into novel delivery systems.